CD4 and metabolic dysfunction-associated steatohepatitis: Finally, for the first time, we have demonstrated that PMNs of NASH patients were able to suppress the proliferation and the activation of autologous CD4+ and CD8+ T cells compared to PMNs from healthy donors and NAFL patients (Figure 5(a)).